Cargando…
Outcome Comparison of High-Risk Native American Patients Who Did or Did Not Receive Monoclonal Antibody Treatment for COVID-19
This quality improvement study compares outcomes among high-risk Native American patients who did or did not receive monoclonal antibody treatment for COVID-19.
Autores principales: | Close, Ryan M., Jones, T. Shaifer, Jentoft, Christopher, McAuley, James B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8456379/ https://www.ncbi.nlm.nih.gov/pubmed/34546375 http://dx.doi.org/10.1001/jamanetworkopen.2021.25866 |
Ejemplares similares
-
494. Characteristics and Outcomes of COVID-19 in Hospitalized Native American Patients: A Single-Site Retrospective Analysis
por: Jones, T Shaifer, et al.
Publicado: (2021) -
Evaluation of respiratory complications in a cohort of preterm infants who did not receive palivizumab monoclonal antibodies
por: Bonati, Poliana Castro de Resende, et al.
Publicado: (2022) -
Disparate Effects of Invasive Group A Streptococcus on Native Americans
por: Close, Ryan M., et al.
Publicado: (2020) -
Prospective Comparison of Hepatocellular Carcinoma Behavior and Survival of Patients who Did or Did not Receive HCV Direct-Acting Antivirals
por: El-Kassas, Mohamed, et al.
Publicado: (2023) -
Who Did It?
por: Bainbridge, Laura
Publicado: (1887)